Cargando…

Remote Patient Monitoring for the Detection of COPD Exacerbations

BACKGROUND: COPD exacerbations occur more frequently with disease progression and are associated with worse prognosis and higher healthcare expenditure. PURPOSE: To utilize a networked system, optimized with statistical process control (SPC), for remote patient monitoring (RPM) and to identify poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Christopher B, Sirichana, Worawan, Arnold, Michael T, Neufeld, Eric V, Taylor, Michael, Wang, Xiaoyan, Dolezal, Brett A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519812/
https://www.ncbi.nlm.nih.gov/pubmed/33061338
http://dx.doi.org/10.2147/COPD.S256907
_version_ 1783587647405424640
author Cooper, Christopher B
Sirichana, Worawan
Arnold, Michael T
Neufeld, Eric V
Taylor, Michael
Wang, Xiaoyan
Dolezal, Brett A
author_facet Cooper, Christopher B
Sirichana, Worawan
Arnold, Michael T
Neufeld, Eric V
Taylor, Michael
Wang, Xiaoyan
Dolezal, Brett A
author_sort Cooper, Christopher B
collection PubMed
description BACKGROUND: COPD exacerbations occur more frequently with disease progression and are associated with worse prognosis and higher healthcare expenditure. PURPOSE: To utilize a networked system, optimized with statistical process control (SPC), for remote patient monitoring (RPM) and to identify potential predictors of COPD exacerbations. METHODS: Seventeen subjects, mean (SD) age of 69.7 (7.2) years, with moderate to severe COPD received RPM. Over 2618 patient-days (7.17 patient-years) of monitoring, we obtained daily symptom scores, treatment adherence, self-reported activity levels, daily spirometry (SVC, FEV(1), FVC, PEF), inspiratory capacity (IC), and oxygenation (SpO(2)). These data were used to identify predictors of exacerbations defined using Anthonisen and other criteria. RESULTS: After implementation of SPC, concordance analysis showed substantial agreement between FVC (decrease below the 7-day rolling average minus 1.645 SD) and self-reported healthcare utilization events (κ=0.747, P<0.001) as well as between increased use of inhaled short-acting bronchodilators and exacerbations defined by two Anthonisen criteria (κ=0.611, P<0.001) or modified Anthonisen criteria (κ=0.622, P<0.001). There was a moderate agreement between FEV(1) (decrease >1.645 SD below the 7-day rolling average) and self-reported healthcare utilization events (κ=0.475, P<0.001) and between SpO(2) less than 90% and exacerbations defined by two Anthonisen criteria (κ=0.474, P<0.001) or modified Anthonisen criteria (κ=0.564, P<0.001). CONCLUSION: Exacerbations were best predicted by FVC and FEV(1) below the one-sided 95% confidence interval derived from SPC but also by increased use of inhaled short-acting bronchodilators and fall in oxygen saturation. An RPM program that captures these parameters may be used to guide appropriate interventions aimed at reducing healthcare utilization in COPD patients.
format Online
Article
Text
id pubmed-7519812
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75198122020-10-14 Remote Patient Monitoring for the Detection of COPD Exacerbations Cooper, Christopher B Sirichana, Worawan Arnold, Michael T Neufeld, Eric V Taylor, Michael Wang, Xiaoyan Dolezal, Brett A Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: COPD exacerbations occur more frequently with disease progression and are associated with worse prognosis and higher healthcare expenditure. PURPOSE: To utilize a networked system, optimized with statistical process control (SPC), for remote patient monitoring (RPM) and to identify potential predictors of COPD exacerbations. METHODS: Seventeen subjects, mean (SD) age of 69.7 (7.2) years, with moderate to severe COPD received RPM. Over 2618 patient-days (7.17 patient-years) of monitoring, we obtained daily symptom scores, treatment adherence, self-reported activity levels, daily spirometry (SVC, FEV(1), FVC, PEF), inspiratory capacity (IC), and oxygenation (SpO(2)). These data were used to identify predictors of exacerbations defined using Anthonisen and other criteria. RESULTS: After implementation of SPC, concordance analysis showed substantial agreement between FVC (decrease below the 7-day rolling average minus 1.645 SD) and self-reported healthcare utilization events (κ=0.747, P<0.001) as well as between increased use of inhaled short-acting bronchodilators and exacerbations defined by two Anthonisen criteria (κ=0.611, P<0.001) or modified Anthonisen criteria (κ=0.622, P<0.001). There was a moderate agreement between FEV(1) (decrease >1.645 SD below the 7-day rolling average) and self-reported healthcare utilization events (κ=0.475, P<0.001) and between SpO(2) less than 90% and exacerbations defined by two Anthonisen criteria (κ=0.474, P<0.001) or modified Anthonisen criteria (κ=0.564, P<0.001). CONCLUSION: Exacerbations were best predicted by FVC and FEV(1) below the one-sided 95% confidence interval derived from SPC but also by increased use of inhaled short-acting bronchodilators and fall in oxygen saturation. An RPM program that captures these parameters may be used to guide appropriate interventions aimed at reducing healthcare utilization in COPD patients. Dove 2020-08-24 /pmc/articles/PMC7519812/ /pubmed/33061338 http://dx.doi.org/10.2147/COPD.S256907 Text en © 2020 Cooper et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Cooper, Christopher B
Sirichana, Worawan
Arnold, Michael T
Neufeld, Eric V
Taylor, Michael
Wang, Xiaoyan
Dolezal, Brett A
Remote Patient Monitoring for the Detection of COPD Exacerbations
title Remote Patient Monitoring for the Detection of COPD Exacerbations
title_full Remote Patient Monitoring for the Detection of COPD Exacerbations
title_fullStr Remote Patient Monitoring for the Detection of COPD Exacerbations
title_full_unstemmed Remote Patient Monitoring for the Detection of COPD Exacerbations
title_short Remote Patient Monitoring for the Detection of COPD Exacerbations
title_sort remote patient monitoring for the detection of copd exacerbations
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519812/
https://www.ncbi.nlm.nih.gov/pubmed/33061338
http://dx.doi.org/10.2147/COPD.S256907
work_keys_str_mv AT cooperchristopherb remotepatientmonitoringforthedetectionofcopdexacerbations
AT sirichanaworawan remotepatientmonitoringforthedetectionofcopdexacerbations
AT arnoldmichaelt remotepatientmonitoringforthedetectionofcopdexacerbations
AT neufeldericv remotepatientmonitoringforthedetectionofcopdexacerbations
AT taylormichael remotepatientmonitoringforthedetectionofcopdexacerbations
AT wangxiaoyan remotepatientmonitoringforthedetectionofcopdexacerbations
AT dolezalbretta remotepatientmonitoringforthedetectionofcopdexacerbations